Paper Details
Full metadata, abstract, citation, and access status.
Analysis of Ginkgo biloba's Potential to Reduce Monosodium Glutamate-Induced Hepatic Damage in Albino Rats
Abstract
Background: The current study investigates the histopathology of monosodium glutamate (MSG) which is a commonly used food additive that has potential hepatotoxic effects and can be countered with Ginkgo biloba extract (GBE) for their ability as hepatoprotective agent. Methods: A total of 21 adult albino Wistar rats weighing between 150 and 200 g were randomly allocated into three groups (n = 7 per group). Group A was control; Group B received oral monosodium glutamate (MSG) [0.08 mg/g body weight] and Group C was given oral MSG with agar extract (AE) [0.08 mg/g MSG + 0.05 mg/g AE], administered for a period of 45 days. At the end of the experiment, liver samples were isolated, fixed in formaldehyde and prepared for histological assessment. Results: Admission of MSG also produced significant liver changes in leukocyte infiltration (P = 0.001), and centrilobular haemorrhagic necrosis (P = 0.001) and central venous congestion (P = 0.001). Further research is necessary since hepatic fibrosis did not exhibit statistically significant alterations (P = 0.27). Co-administration of GBE showed hepatoprotective benefits, improving hepatocyte regeneration, facilitating tissue healing, and lessening the degree of lesions caused by MSG. Conclusion: While ginkgo biloba extract protects and regenerates hepatic tissue, MSG markedly causes hepatotoxicity in albino rats. Its potential to prevent hepatic fibrosis has to be studied more thoroughly.
To Cite This Article
Not Recommended

